Bladder Cancer | Ashish M Kamat, MD, MBBS

The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer — Faculty Presentation #3: Integrating Immune Checkpoint Inhibitors into the Current Treatment Paradigm for Non-Muscle-Invasive Bladder Cancer — Dr Kamat CME information and select publications